New Pyrazolo[3,4-d]pyrimidine Dual Inhibitors Target Cancer
In the relentless pursuit of effective cancer therapies, pyrazolopyrimidine-based dual inhibitors have emerged as a promising innovation. Recent studies, particularly those conducted by Jiang, H.,...















